Collaboration Inquiries
Latest News Press Release Recent Articles Current & Upcoming Meetings and Events Past Meetings and Events
Contact Information
VacciMax® Platform Advantage VacciMax® Proof of Concept VacciMax® Platform Scale-up
Board of Directors Corporate Profile In Memorium Scientific Advisors Senior Management Technical Advisors
Contact Us Partners Press Releases Spayvac Vaccimax Corporate Profile Home
  HOME | PROFILE | VACCIMAX® PLATFORM | PRESS | PARTNERS | CAREERS | CONTACT  


Delivering Breakthrough Vaccines

IVT’s goal is to generate sustainable, long-term revenues by developing and commercializing VacciMax® based vaccines through early clinical development, multiple partnerships and licensing agreements with major vaccine companies.

LATEST NEWS

Vaccine Development Aided by New Techniques

On The Move - ImmunoVaccine Technologis Inc. has been selected as one of Canada's Top 10 Life Sciences Companies

Vaccine breakthrough heralds new cancer treatment

ImmunoVaccine Technologies’ DepoVax™ Shows Positive Results for Cancer and Infectious Diseases

ImmunoVaccine Technologies selected as Canada's Top 10™ Life Sciences Companies

 

CURRENT AND UPCOMING MEETING AND EVENTS

Events


Bio Asia 2009

 

January 19-20, 2009

Tokyo, Japan

Grand Hyatt Tokyo

 

Dr. Randal Chase, President & CEO will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail eks.ivt@immunovaccine.com.


Related Link: http://bioasia.bio.org/opencms/bioasia/2009/index.jsp


7th Annual BioPartnering North America

 

February 8 - 10, 2008 

The Weston Bayshore Resort 

1601 Bayshore Drive

Vancouver, British Columbia

 

Dr. Randal Chase, President & CEO will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail eks.ivt@immunovaccine.com.

 


Related Link: http://www.techvision.com/bpn/

  HOME | PROFILE | PRODUCT | PRESS | PARTNERS | CAREERS | CONTACT